BONK, INC.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
BNKK$1.00+2.0%Stored close · as of Nov 6, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-13.
0001493152-26-022743
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-14.
0001493152-26-038241
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 108 previous paragraphs and 119 current paragraphs.
93 unchanged; 12 reworded; 11 added; 3 removed; 0 previous and 3 current paragraphs rearranged.
Tables are not compared: 4 previous and 5 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (11)
Current report
Operating expenses for the three months ended June 30, 2026 were in connection with our daily operations as follows: (i) marketing expenses of $168,741; (ii) research and development of $0; (iii) legal and professional expenses of $807,638, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $17,246; (v) depreciation and amortization of $164,527; (vi) general and administrative expenses of $971,110, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $295,347.
Current report
Other income (expense) for the three months ended June 30, 2026 included: (i) net interest expense of $9,135; (ii) tax expense of $47,248; (iii) net gain on settlement of $419,092 and loss on deconsolidation of 54,640; (iv) realized gain on exchange of digital assets of 37,498; (v) unrealized loss on digital assets of $4,335,567, and (vii) unrealized loss on equity investments of 31,114.
Current report
Operating expenses for the three months ended June 30, 2025 were in connection with our daily operations as follows: (i) marketing expenses of $863,620; (ii) research and development of $6,517; (iii) legal and professional expenses of $1,413,402, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $45,200; (v) depreciation and amortization of $110,793; (vi) general and administrative expenses of $982,243, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $911,731.
Current report
Net income (losses) were $(6,054,673) and $13,374,947 for the three months ended June 30, 2026 and 2025, respectively.
Current report
For the six months ended June 30, 2026 and 2025
Current report
Revenues
Current report
We had total operating expenses of $4,645,181 for the six months ended June 30, 2026 compared to $9,774,838 for the six months ended June 30, 2025.
Current report
Other income for the six months ended June 30, 2026 included: (i) net interest expense of $31,030; (ii) tax expense of $47,248; (iii) gain on settlement of $419,092 and loss on deconsolidation of $53,034; (iv) gain on sale of marketable securities of $796,404; (v) realized loss on exchange of digital assets of 170,031; (vi) unrealized loss on digital assets of $8,167,423, (vii) unrealized gain on equity investments of 17,444 and (viii) other income of $13,600.
Current report
Operating expenses for the six months ended June 30, 2025 were in connection with our daily operations as follows: (i) marketing expenses of $1,220,051; (ii) research and development of $15,522; (iii) legal and professional expenses of $3,563,638, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $111,769; (v) depreciation and amortization of $221,585; (vi) general and administrative expenses of $1,715,498, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $2,897,107.
Current report
Income/Losses
Current report
Net income (losses) were $(7,883,314) and $8,048,014 for the six months ended June 30, 2026 and 2025, respectively.
Removed paragraphs (3)
Previous report
Our research and development team in continually looking to develop new therapeutic products, while continually improving and enhancing our existing products and product candidates to address customer demands and emerging trends.
Previous report
Operating expenses for the three months ended March 31, 2025 were in connection with our daily operations as follows: (i) marketing expenses of $356,430; (ii) research and development of $9,005; (iii) legal and professional expenses of $2,150,236, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $66,237; (v) depreciation and amortization of $110,792; (vi) general and administrative expenses of $733,249, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $1,985,376.
Previous report
Net losses were $1,828,643 and $5,326,933 for the three months ended March 31, 2026 and 2025, respectively.
Reworded paragraphs (12)
Previous wording
The Sure Shot Dietary Supplement was launched on our own website and through Amazon in December 2023 and with several Big Box stores. The Company is advancing several product formats and formulations to continue to offer a wide array of products that can be purchased at various locations that coincide with consumer shopping habits. In particular, the Company plans to develop new flavors for each of its current SKUs (4 oz. and “Stick Pack”).
Current wording
The Sure Shot Dietary Supplement was launched on our own website and through Amazon in December 2023 and with several Big Box stores.
Previous wording
We primarily sell our products through e-commerce websites including Amazon. To drive loyalty, word-of-mouth marketing, and sustainable growth, we invest in customer experience and customer relationship management. Our marketing investments are directed towards driving profitable growth through advertising, public relations, and brand promotion activities, including digital platforms, sponsorships, collaborations, brand activations, and channel marketing. Additionally, we continue to invest in our marketing and brand development efforts by investing capital expenditures on product displays to support our channel marketing via our retail partners.
Current wording
We primarily sell our products through e-commerce websites including Amazon. To drive loyalty, word-of-mouth marketing, and sustainable growth, we invest in customer experience and customer relationship management. Our marketing efforts are focused primarily on Yerbaé’s plant-based energy beverage products and the Company has substantially reduced any marketing of the Sure Shot Dietary Supplement.
Previous wording
The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Caring Brands, Inc., a Florida corporation, Jupiter Wellness Investments, Inc., a Florida corporation, and for the period from January 1, 2022 to August 14, 2023, SRM Entertainment, Limited, a Hong Kong private limited company, which was sold effective August 14, 2023. All intercompany accounts and transactions have been eliminated.
Current wording
The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Jupiter Wellness Investments, Inc., Yerbae Brands Inc, and Bonk Holdings, LLC. All intercompany accounts and transactions have been eliminated.
Previous wording
Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited financial statements for the three months ended March 31, 2025 and 2024 and audited financial statements for the year ended December 31, 2024, which have been prepared in accordance with United States generally accepted accounting principles, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission. The preparation of the financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenue generated, and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.
Current wording
Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited financial statements for the six months ended June 30, 2026 and 2025 and audited financial statements for the year ended December 31, 2025, which have been prepared in accordance with United States generally accepted accounting principles, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission. The preparation of the financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenue generated, and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.
Previous wording
The Company’s deferred tax asset at March 31, 2026 and December 31, 2025 consist of net operating loss carry forwards calculated using federal and state effective tax rates equating to approximately $9,303,095 and $8,919,080, respectively, less a valuation allowance in the amount of approximately $9,303,095 and $8,919,080, respectively. Due to the Company’s lack of earnings history, the deferred tax asset has been fully offset by a valuation allowance in the three months ended March 31, 2026 and year ended December 31, 2025.
Current wording
The Company’s deferred tax asset at June 30, 2026 and December 31, 2025 consist of net operating loss carry forwards calculated using federal and state effective tax rates equating to approximately $10,574,576 and $8,919,080, respectively, less a valuation allowance in the amount of approximately $10,574,576 and $8,919,080, respectively. Due to the Company’s lack of earnings history, the deferred tax asset has been fully offset by a valuation allowance in the three months ended June 30, 2026 and year ended December 31, 2025.
Previous wording
The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $300 and $9,005 for the three-months ended March 31, 2026, and 2025, respectively.
Current wording
The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $300 and $15,522 for the six-months ended June 30, 2026, and 2025, respectively.
Previous wording
The following table provides selected financial data about us for the three months ended March 31, 20265 and 2025, respectively.
Current wording
The following table provides selected financial data about us for the three months ended June 30, 2026 and 2025, respectively.
Previous wording
We generated $4,337,057 in revenues for the three months ended March 31, 2026 compared to $42,101 revenues in the three months ended March 31, 2025. The increase is due to the Company added sales from Yerbae Brands Inc. and the Company’s Revenue Share Agreement with LetsBonk.fun.
Current wording
We generated $792,937 in revenues from beverage and $370,469 from related party revenue share for the three months ended June 30, 2026 compared to $44,948 revenues in the three months ended June 30, 2025. The increase is due to the Company added sales from Yerbae Brands Inc. and the Company’s Revenue Share Agreement with LetsBonk.fun.
Previous wording
We had total operating expenses of $2,218,968 for the three months ended March 31, 2026 compared to $5,411,325 for the three months ended March 31, 2025.
Current wording
We had total operating expenses of $2,424,609 for the three months ended June 30, 2026 compared to $4,363,514 for the three months ended June 30, 2025.
Previous wording
Other income for the three months ended March 31, 2025 included: (i) interest income of $11,376; (ii) interest expense of $103,450; (iii) other expense of $25,080 and (iv) net gain on sale of stock of $180,557.
Current wording
Other income for the six months ended June 30, 2025 included: (i) interest income of $18,740; (ii) interest expense of $119,678; (iii) other expense of $25,080 and (iv) loss on settlement of $362,430 and (v) unrealized gain on equity investment of $18,190,351.
Previous wording
Operating expenses for the three months ended March 31, 2026 were in connection with our daily operations as follows: (i) marketing expenses of $211,603; (ii) research and development of $300; (iii) legal and professional expenses of $699,107, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $26,494; (v) depreciation and amortization of $201,212; (vi) general and administrative expenses of $964,452, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $115,801.
Current wording
Operating expenses for the six months ended June 30, 2026 were in connection with our daily operations as follows: (i) marketing expenses of $380,345; (ii) research and development of $300; (iii) legal and professional expenses of $1,506,745, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $78,277; (v) depreciation and amortization of $365,738; (vi) general and administrative expenses of $1,902,629, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $411,147.
Previous wording
Other income for the three months ended March 31, 2026 included: (i) interest income of $8,255; (ii) interest expense of $30,150; (iii) other income of $13,680; (iv) gain on sale of marketable securities of $796,404; and (v) unrealized loss on digital assets of $3,831,935.
Current wording
Other income for the six months ended June 30, 2025 included: (i) interest income of $7,364; (ii) interest expense of $233,128; (iii) gain on sale of stock of $180,556; (iv) loss on settlement of $362,430 and (v) unrealized gain on equity investment of $18,190,351.
Rearranged current paragraphs (3)
Current report — wording carried from elsewhere
The following table provides selected financial data about us for the six months ended June 30, 2026 and 2025, respectively.
Current report — wording carried from elsewhere
We generated $1,579,268 in revenues from beverage and $3,921,195 from related party revenue share for the six months ended June 30, 2026 compared to $87,049 revenues in the six months ended June 30, 2025. The increase is due to the Company added sales from Yerbae Brands Inc. and the Company’s Revenue Share Agreement with LetsBonk.fun.
Current report — wording carried from elsewhere
Operating Expenses and Other Income (Expense)